INTRODUCTION
There is evidence that routine outcome monitoring (ROM) has a positive influence on treatment efficacy (Lambert, 2010) and efficiency (Delgadillo et al., 2017) in mental health care. Routine measurements can be used in individual treatments by clinicians and patients to determine progress and the necessity to adapt interventions (Van, Dekker, Peen, van Aalst, & Schoevers, 2008) , but they may also be used to evaluate the overall effectiveness of treatment programs, both within the same patient group as across diagnoses. The second goal could also include benchmarking, comparing outcomes of different teams or This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. providers, in order to learn from each other and to improve treatment modalities (Barendregt, 2015) . In the Netherlands, ROM has been implemented in mental healthcare with the aim to improve outcomes on the level of individual treatments as well as on the level of teams or providers (de Beurs, Barendregt, & Warmerdam, 2017) . In terms of instruments, there is debate on whether the same instrument can be used for both goals, and which goal should be prioritized when time and effort are limited (Meesters, Duijzer, Nolen, Schoevers, & Ruhé, 2016) .
Among measures to assess treatment outcome of depression, a distinction can be made between disorder-specific instruments, such as the Beck Depression Inventory (BDI) or the Inventory of Depress Anxiety. 2019;36:93-102.
wileyonlinelibrary.com/journal/da Depressive Symptomatology (IDS), and generic instruments for general psychopathology, such as the Outcome Questionnaire (OQ-45; Lambert, Gregersen, & Burlingame, 2004) or the Symptom Checklist/Brief Symptom Inventory (SCL-90/BSI; Derogatis, 1975a Derogatis, , 1975b .
Advantage of generic instruments is that they allow for a comparison of treatment outcomes across diagnoses. Furthermore, they are convenient for use in everyday clinical practice, as the same instrument can be used to assess all patients. However, generic instruments may be less informative regarding specific symptoms of depression and less responsive to change as compared to instruments specifically designed to assess the severity of depression (Meesters et al., 2016) .
The literature on the comparative responsiveness of generic and disorder-specific measures is expansive, but results are far from conclusive (Beaton, Bombardier, Katz, & Wright, 2001; Husted, Cook, Farewell, & Gladman, 2000; Terwee et al., 2007) . Some studies report greater responsiveness of disorder-specific measures (Husted et al., 2000; Reine et al., 2005; Wiebe, Guyatt, Weaver, Matijevic, & Sidwell, 2003) ; others do not find a difference (Ades, Lu, & Madan, 2013; McCrindle et al., 2014; Tu, Hwang, Hsu, & Ma, 2017) . The findings depend on the measures that are compared, the concepts assessed (e.g., quality of life vs. symptoms), the patient population under investigation, and the statistical approach chosen to investigate responsiveness (Terwee, Dekker, Wiersinga, Prummel, & Bossuyt, 2003) . Several studies compare generic and disorder-specific measures of health-related quality of life (Ades et al., 2013; Wiebe et al., 2003) , but comparisons between measures of clinical symptoms of mental disorders are less common (Hansson, Chotai, Nordstöm, & Bodlund, 2009; Wahl et al., 2014) .
In psychiatry, research comparing responsiveness of generic and disorder-specific instruments for the assessment of the severity of psychopathology, is rather scarce. Most research compares quality of life measures, such as the EQ-5D and the SF-36 (Brazier et al., 2014) , or is limited to cross-sectional analysis (Mauriño, Cordero, & Ballesteros, 2012 Responsiveness can be investigated by comparing results of different studies using distinct measures (Kounali, Button, Lewis, & Ades, 2016) , but a stronger design is a "head-to-head" comparison of instrument in the same study (Wiebe et al., 2003) . Responsiveness is investigated with correlational analyses or by comparing effect sizes (ES) of pre-to-posttest change according to various outcome measures (de Beurs et al., 2012; Husted et al., 2000) . Responsiveness is best assessed and compared by investigating the course of scores over time of measures from the same longitudinal dataset. Although two assessments suffice to detect a difference in responsiveness, additional assessments allow for a more fine-grained analysis, for instance, detecting desynchrony of response over time (patients may change first on one measure and in a later phase of their treatment on another measure).
For an ongoing benchmark project in the Netherlands by Stichting Benchmark GGZ, the use of generic outcome scales is prescribed, such as the BSI (Derogatis, 1975a) , the OQ-45 (Lambert et al., 2004) , and the recently developed Dutch Symptoms Questionnaire-48 (Carlier et al., 2012; Carlier et al., 2017) , to assess the outcome of treatment of psychiatric patients. However, a debate arose about the suitability of generic outcome scales (Meesters et al., 2016) , as disorder-specific instruments, such as the BDI (Beck & Steer, 1990) , the Inventory of Depressive Symptoms Self-report (IDS-SR; Rush, Gullion, Basco, Jarrett, & Trivedi, 1996) , and the Mood and Anxiety Symptoms Questionnaire (MASQ; Watson et al., 1995) , are possibly more responsive. Consequently, changes in symptomatology within patients may go unnoticed and we might get a too conservative estimate of the benefits of mental health care. Also, differences in performance between various providers may remain obscured when relatively unresponsive outcome measures are used.
In this paper, we report on three comparisons of generic and disorder-specific measures for depression in three separate datasets.
We compared (1) BDI with SCL-90, (2) IDS-SR with OQ-45, and (3) BDI, MASQ, and BSI. We compared total scores on these instruments, but also subscale scores. Our hypothesis is that responsiveness improves with increased specificity for depression of the (sub)scale. We will also explore the data for signs of desynchrony in change over time between (sub)scales of the investigated instruments, as disorder-specific scales may detect change at an earlier phase of treatment than generic ones. Sheehan et al., 1998; van Vliet & de Beurs, 2007) . In Groningen, diagnoses (DSM IV)
METHODS

Source of the data
were determined in an intake session by a clinician.
All data were collected by ROM (de Beurs et al., 2011) . Patients in ambulatory care, mostly seen weekly for psychological treatment and/or pharmacological treatment, were assessed at fixed intervals during their treatment, usually every 3 to 4 months. As treatments vary in duration, the number of assessments per patient varies as well. Data of instruments were matched on ID of the respondent and assessment moment (a match was declared when the assessment of the instruments had taken place in the same week, which was usually at the same occasion). The first dataset yielded longitudinal data with minimally two and a maximum of five consecutive assessments (N = 233); the second and third yielded a maximum of 10 assessments (N = 832 and N = 3,409, respectively). Patients gave permission for the (anonymized) use of their data for scientific purposes.
Measures
Disorder specific
The BDI-II (Beck & Steer, 1990 ) is a revised version of the original BDI (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) and the most commonly used self-report instruments to assess the severity of depression. The questionnaire includes 21 items and each item has a set of four unique response options (0-3). For the Dutch translation, the BDI total score (BDI-TOT) and three subscale scores can be computed: the BDI cognitive factor (BDI-COG) with seven items, the BDI affective factor (BDI-AFF) with five items, and the BDI somatic factor (BDI-SOM) with nine items (van der Does, 2002).
The IDS-SR (Rush et al., 1996) also measures the severity of depression and includes 30 items with unique response options on a 4-point scale. A total score for 28 items (IDS-TOT) and two subscale scores for mood/cognition (IDS-MOOD) with 11 items and anxiety/arousal (IDS-ANX) with eight items (Wardenaar et al., 2010) .
The MASQ (Watson et al., 1995) was developed to assess the symptoms of depression and anxiety disorders more distinctively. Items describe symptoms shortly and all have the same five response options on a Likert scale (not at all to very much). A total score (MASQ-TOT, 90 items) and subscale scores can be calculated for (lack of) positive affect (MASQ-PA; 22 items and specific for mood disorders), Somatic Anxiety (MASQ-SA; 18 items and specific for anxiety disorders) and negative affect (MASQ-NA; 20 items and nonspecific to depression or anxiety). The factorial structure is replicated in the Dutch transla- 
Generic specific
The SCL-90 (Derogatis, 1975b ) is a generic self-report questionnaire for the severity of psychopathology (Koeter, Ormel, & van den Brink, 1988) . The checklist includes 90 short descriptions of problems or symptoms, and respondents are asked to indicate how much they were bothered in the last week on a Likert scale with five response options (not at all to very much). The total score (SCL-TOT) is the sum of all responses with a range of 90-450. The Dutch translation has good psychometric properties (Arrindell & Ettema, 1986) , but uses a different dimensional structure than the U.S. original with eight subscales: anxiety, agoraphobia, depression (SCL-DEP), somatization, insufficiency in thinking or behavior (SCL-IN), interpersonal sensitivity, hostility (SCL-HOS), and sleeping problems.
The BSI (Derogatis, 1975a ) is a shortened version of the SCL-90 with 53 items with identical instructions and response options. The total score on the 53 items is the BSI-TOT and is calculated as the mean score on all items with a range of 0-4. The Dutch BSI has nine subscales-in accordance with the U.S. original-of each five to six items: depression (BSI-DEP), somatization (BSI-SOM), anxiety, phobia, interpersonal sensitivity, obsessive compulsive, hostility, paranoia, and psychoticism. The Dutch version of the BSI has good psychometric properties (de Beurs & Zitman, 2006) . The dichotomy of generic and disorder-specific does not hold when subscale scores on generic instruments are also taken into consideration. Table 1 shows a proposal on how to place instruments and their subscales on the dimension generic-depression specific. The OQ-TOT is deemed the most generic as this score includes functioning as well as symptomatology. Next, the OQ-SD and the SCL-90/BSI-TOT assess general symptomatology/psychopathology. The MASQ-TOT is somewhat more specific, assessing only symptoms of mood and anxiety disorders. Negative affect is specific to depression at the same level as the BDI-TOT and IDS-TOT. Finally, the IDS-SR and BDI-subscales and the MASQ-PA are deemed to be the most specific for depression.
Statistical analyses
To put all instruments on a common metric, scores were standardized on the pretest mean and standard deviation. Consequently, the entire population gets a baseline score of M = 0 (SD = 1) on all scales. Scores diminish over time and the absolute value of mean score at consecutive assessments represents the within groups effect size (ES) for each (sub)scale. We established the ES for the first and second assessment (initial treatment phase) and for the first and last available (nth) assessment (the maximum pre-to-posttest change).
In each dataset, the correlations between (sub)scales of instruments at baseline and at the last available assessment were calculated, Furthermore, the correlations between difference scores for the first assessment interval and for the maximum interval (first to nth assessment) were calculated. High correlations between differences scores suggest similar responsiveness.
Responsiveness was also investigated with repeated measures ANOVAs on subsets of the three samples with complete data for three, TA B L E 1 Position of total scale scores and subscale scores of the instruments on the dimension from generic to disorder-specific Notes. OQ-TOT, OQ-45 total score; OQ-SD, symptomatic distress; OQ-IR, interpersonal relations; IDS-TOT, IDS-SR total score; IDS-MOOD, mood symptoms; BDI-TOT, BDI total score; BDI-AFF, affective factor; BDI-COG, cognitive factor; SCL/BSI-TOT, SCL-90 or BSI total score; SCL/BSI-DEP, SCL-90 or BSI depression; MASQ-TOT, MASQ total score; MASQ-NA, negative affect; MASQ-PA, (lack of) positive affect.
four, or five assessments. For instance, as the first dataset yielded sufficient subjects with at least three assessments, we compared their total score on the SCL-90 with their total score on the BDI with a repeated measures ANOVA in a 2 (instrument) × 3 (time) factorial design (see Table 3 ); in a similar vein, we compared the SCL-90 depression subscale score with the BDI-TOT. These two ANOVAs were repeated for the maximum treatment effect in a 2 (instrument) × 2 (time; the first and the nth assessment) design. All analyses yield a time effect 
RESULTS
The three datasets
In the dataset for the comparison of the BDI and the SCL-90 (N = 233), the mean age of respondents was M = 33.7 years (SD = 11.1) and 52.8% was female. All patients suffered from a mood disorder, although this was not for all the primary diagnosis. According to their primary diag- 
Comparison of BDI and SCL-90
Supporting Information Table A shows Pearson correlation coefficients between BDI and SCL-90 (sub)scales at baseline, at the last assessment, and for the difference score for the first assessment interval (and for the maximal difference score, the first to nth assessment).
The correlations are of medium or high size (>0.70); correlations between the BDI-TOT, the SCL-TOT, and the SCL-DEP are the highest.
This applies to the cross-sectional correlations, but also for the longitudinal difference scores. At first glance, these scales measure the same concept, and difference scores are also substantially associated (Supporting Information Table B ). For this dataset, 160 patients had complete data at three assessments and their data were analyzed with repeated measures ANOVAs.
The results are presented in Table 3 and Notes. BDI, BDI total score; SCL-TOT, SCL-90 total score; SCL-DEP, SCL-90 Depression subscale; statistically significant main and interaction effects (P < 0.05) are indicated by 2 in bold typeface. 
Comparison of IDS-SR and OQ-45
Supporting Information Table C presents A subset of these data was analyzed with repeated measures
ANOVAs. As Table 4 shows, only the analyses comparing subscales of the instruments yield a significant (but small) interaction effect. The contrasts in Supporting Information Table D show that also in this dataset, the largest decrease in scores occurs in the first months of treatment ( 2 = 0.121, 0.055, and 0.029 in the first three phases of treatment). The only significant interaction effect is the difference in responsiveness between the IDS-MOOD and the OQ-IR subscale during the second treatment phase ( 2 = 0.24).
The course of scores over at least four assessments is depicted in Figure 2 
Comparison of BDI, MASQ, and BSI
Supporting Information Clark, Watson, & Mineka, 1994) is less strongly correlated with depression according to the BDI or the BSI-DEP score. Figure 1 (right Table 5 shows the results of repeated measures ANOVAs. The scores of five assessments were used. There were significant differences in responsiveness between total and subscale scores (small to intermediate 2 ), which is illustrated in Figure 1 Finally, all analyses were repeated for more homogenous diagnostic groups of only patients diagnosed with depression and patients diagnosed with singular depression (without comorbid conditions). Notes. IDS, IDS-SR total score; OQ-TOT, total score; OQ-subs, OQ-45 subscales; OQ-SD, symptomatic distress subscale; statistically significant main and interaction effects (P < 0.05) are indicated by 2 in bold typeface. Notes. TOT-scales, total score on BDI, MASQ, and BSI; BDI, BDI-total score; PA, MASQ-positive affect; BSI-DEP, BSI-depression.
By and large, the findings of these analysis regarding the comparative responsiveness of the instruments mimicked the results found with the entire sample, as reported in Table 5 and Supporting Information Tables E, F, and G. Correlational analyses and ANOVAs with the mood disorder samples were similar to the earlier findings; the pre-toposttest change on scales was somewhat larger in comparison to the diagnostically more heterogeneous samples (∼0.10 ES points), but the comparative responsiveness remained the same.
DISCUSSION
Correlational analyses revealed a pattern of associations among the measures and their subscales, which is in line with the concepts they intend to measure. Associations among (difference) scores between (sub)scales for the same construct are high and lower for distinct constructs. Correlations between difference scores tend to be lower compared to correlations between scores at single assessment occasions, due to inter-individual variation in change and due to the lower reliability of difference scores. Measurement errors at both time points limit the reliability of difference scores, which is by definition lower than the reliability of single scores (Cronbach, 1984) . At first glance, especially the correlational results between difference scores suggest similar responsiveness of generic and disorder-specific instruments for depression.
Repeated measures ANOVA revealed differences in responsiveness in two of the three datasets in the expected direction: disorder-specific scales tend to be more responsive than total scores on generic scales, although the ES of the statistically significant time-by-instrument effects are small. Generally, no evidence of desynchrony in response was found. The most responsive scale is the BDI-TOT, but not its subscale scores. The BDI-TOT is 1.3 times more responsive than the SCL-90 total score in the first dataset and 1.4 times more responsive than the BSI-total score in the third dataset. Differences between the BDI-TOT and the depression subscales of the SCL-90 or BSI are somewhat less pronounced, but the BDI is still 1.2 times more responsive. The differences in responsiveness between the instruments may be due to According to the ANOVA for repeated measurements, the depression subscales of the SCL-90 (Table 3 and Supporting Information   Table B ) and the BSI (Table 5 and Supporting Information Table G ) do not differ from the most responsive subscale of the BDI in their ability to detect chance. Thus, our hypothesis that the most specific scales will be the most responsive is not fully confirmed by the results. Within the generic SCL-90 and BSI, subscales for depression are more responsive than total scores on these instruments, but within the disorder-specific BDI and IDS, subscales are generally not more responsive than the total scores. Finally, we see no desynchrony in responsiveness among the compared (sub)scales.
The three samples in this study were composed of patients with common mental disorders, predominantly depression, but also some patients with anxiety or somatoform disorders were included, who did not meet formal diagnostic criteria for a (comorbid) mood disorder.
The findings should be interpreted with caution as the data were obtained in everyday clinical practice and stem from a somewhat heterogeneous sample. Repeating the analyses in the sample, after removing the patients without a depression diagnosis, did not alter the results in a meaningful way. Finally, we reanalyzed the data from patient with a singular mood disorder (which was only possible in the Leiden sample with complete diagnostic information). The results
were highly similar to the initial findings, except for lower baseline scores of patients with a singular mood disorder and a slight increase in the pre-to-posttest change in the pure depression groups compared to the more diagnostically mixed samples. Apparently, both in the purer mood disorder samples as well as in the more heterogeneous samples, total scores on disorder specific scales are more responsive than total scores on generic scales. Most items of the BDI or IDS are relevant for this patient group, whereas in the SCL-90 or BSI, there are many items with less relevance, lowering the SCL90 or BSI-TOT at baseline and thus making these scales less responsive to change.
Surprisingly, the second dataset showed that the IDS-SR total score and its subscale scores are not more responsive than the OQ-45 or its subscales. A possible explanation for not finding this expected difference in responsiveness may be that in general less change in symptoms was realized in this sample, comprising relatively treatment-resistant patients, leaving also less room for distinctive responsiveness of both instruments. However, subscale scores on the IDS-SR appear even less responsive compared to subscale scores on the OQ-SD (see Table 4 and Figure 2 [middle]). The IDS was composed by Rush and colleagues (1986) to cover a broad range of symptoms in order to be more sensitive to change than the gold standard for depression assessment at that time, the Hamilton Depression Rating Scale (HDRS; Hamilton, 1960) .
There is a rating scale version to be completed by a clinician (IDS-C) and a self-report version (IDS-SF). Indeed, Rush et al. (1996) Strength of the present study is that the available data offered a unique opportunity for a head-to-head comparison of generic and disorder-specific instruments. A further strength is the size of the three datasets, providing sufficient data to yield ample statistical power to find statistically significant differences in responsiveness between self-report instruments. Furthermore, these data were collected in real-life clinical practice with diverse samples of psychiatric patients (mild to moderate common mental disorders in ambulatory care in the Leiden sample and a mix of in-and outpatients with moderate to severe problems in the samples from Groningen).
Finally, the analyses on three or more assessments allowed us to investigate not only differences in responsiveness among measures, but also to check for potential desynchrony in change over time.
LIMITATIONS
Not all possible comparisons between measures were feasible. Unfortunately, a dataset for a head-to-head comparison of the IDS-SR with the SCL-90 or BSI was not available. The IDS-SR was only compared with the OQ-45, and this subsample showed the lowest ES for the pre-to-posttest change after four assessments, which limits the chance of finding differences in responsiveness between instruments in the first place. Future research should reveal how the IDS-SR and the BSI depression subscale compare in responsiveness. Furthermore, this study compared Dutch versions of self-report questionnaires and we recommend replication of this research with the original versions in English-speaking samples. Finally, all results and conclusions apply to the situation that we want optimal information from aggregated data, for example, when comparing outcomes of patient groups in a randomized controlled trial or in a naturalistic observational study. For ROM, where the focus is on monitoring progress of individual patients, specific information may be required, and this can best be provided by the administration of (subscales of) disorder-specific instruments.
A final limitation of our study is that it merely focused on internal responsiveness or the ability of instruments to measure change over time. The value of the responsiveness index is dependent on the actual change achieved, which may diverge per study of per patient sample, as turned out with our three data sets. In contrast, external responsiveness attempts to denote responsiveness as the relationship between change in a measurement and change in an external standard (Husted et al., 2000) . External responsiveness of an instrument may be expressed in how well it distinguishes between recovered and unchanged groups of patients. Future research may also evaluate the external responsiveness of generic and disorder-specific mental health measures. However, establishing external responsiveness does require an external criterion to decide on the clinical status of psychiatric patients, which is somewhat problematic in common mental disorders, where the transition of functional to dysfunctional is usually gradual. This is in line with a more dimensional approach toward conceptualizing psychopathology. Also, alternative views on the structure of psychopathology (Krueger & Markon, 2006; Walton, Ormel, & Krueger, 2011 ) and other models for the association among psychopathology symptoms and symptom clusters, such as network models, (Borsboom & Cramer, 2013; Fried, Epskamp, Nesse, Tuerlinckx, & Borsboom, 2016) deserve attention in future development and research of outcome measures for depression treatment.
CONCLUSION
In conclusion, the disorder-specific BDI is more responsive compared to the total score on the generic SCL-90, and BSI and the disorderspecific IDS does not appear more responsive than the OQ-45. The responsiveness of the depression subscales of the SCL-90/BSI falls in between. For an efficient assessment of symptomatology in a sample with diverse psychiatric disorders, it may be sufficient to administer a generic instrument, preferably with responsive subscales for specific problems. However, for optimum power to detect differences in a trial or for detailed information on individual patients, use of the more responsive disorder-specific instruments is recommended.
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